Shares of Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV – Get Free Report) dropped 30% during trading on Tuesday . The stock traded as low as $0.70 and last traded at $0.70. Approximately 1,796 shares were traded during trading, an increase of 85% from the average daily volume of 969 shares. The stock had previously closed at $1.00.
Mosaic ImmunoEngineering Stock Down 30.0 %
The company has a market cap of $5.07 million, a PE ratio of -4.67 and a beta of 0.31. The stock’s 50 day simple moving average is $0.88 and its two-hundred day simple moving average is $0.92.
About Mosaic ImmunoEngineering
Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.
Featured Stories
- Five stocks we like better than Mosaic ImmunoEngineering
- Buy P&G Now, Before It Sets A New All-Time High
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
